Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- PSTG +21.5%, CRM +13.3%, OKTA +13.2%, MRVL +12.7%, JBLU +5.6% (guidance), DLTR +3.8%, DSGX +1.7%, RY +1.6%
Other news:
- HRTX +62.7% (favorable court decision)
- SLND +10.5% (receives $60 million wastewater treatment plant project award)
- STOK +7.2% (receives FDA Breakthrough Therapy Designation for Zorevunersen)
- AVIR +6.3% (announces positive results from phase 2 study of bemnifosbuvir and ruzasvir regimen for treatment of Hepatitis C Virus)
- PBI +4.7% (Hestia Capital Management Discloses Additional Information Regarding 10b5-1 Plan at Pitney Bowes)
- GSAT +4.3% (PSN and GSAT announce exclusive partnership)
- BTCM +4.1% (Announces Commitment to Litecoin (LTC) and Dogecoin (DOGE) Mining, Bringing Increased Profitability)
- HIMX +3.5% (approves $20 million share buyback program)
- RLGT +3.1% (acquires TCB Transportation)
- EYPT +3.1% (Announces First Patient Dosed in Second Global Phase 3 LUCIA Clinical Trial of DURAVYU for the Treatment of Wet Age-Related Macular Degeneration)
- TRMK +2.8% (authorizes new $100 mln share repurchase program)
- GENI +2.6% (announces collaboration with TNT Sports and NBA 2K)
- CANF +2.5% (announced that a patient currently treated with Namodenoson in a compassionate use program in Can-Fite's Phase II Liver Cancer Study has an overall survival time of 8 years with a complete response)
- NVAX +2.3% (sells Czech Republic manufacturing site to Novo Nordisk (NVO) for $200 million)
- STC +1.9% (CEO contract extension)
- WULF +1.9% (announces Nov production data)
- SGML +1.4% (production at full capacity; record shipment of quintuple zero green lithium)
- CBT +1.2% (authorizes repurchase of up to 10 mln additional shares)
- TXNM +1.1% (increases dividend)
- VTEX +1.1% (reports Black Friday sales)
- G +1% (signs strategic collaboration agreement with AWS)